Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study

by Kelly M. de Ligt, Annemieke Witteveen, Sabine Siesling, Lotte M. G. Steuten
Published 2018-01-01

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.

by Anna Miquel-Cases, Valesca P Retèl, Bianca Lederer, Gunter von Minckwitz, Lotte M G Steuten, Wim H van Harten
Published 2016-01-01

Comparative cost-effectiveness of focal and total salvage 125 I brachytherapy for recurrent prostate cancer after primary radiotherapy

by Max Peters, Marjanne A. Piena, Lotte M.G. Steuten, Jochem R.N. van der Voort van Zyp, Marinus A. Moerland, Marco van Vulpen
Published 2016-12-01

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

by Valesca P. Retèl, Lotte M. G. Steuten, Marnix H. Geukes Foppen, Janne C. Mewes, Melanie A. Lindenberg, John B. A. G. Haanen, Wim H. van Harten
Published 2018-09-01